August J. Moretti
Overview
August J. Moretti received an average of $2M in total compensation, including $447K in salary, at 4D Molecular Therapeutics between 2021 and 2022. August Moretti also received an average of $1M at DepoMed from 2012 to 2018.
- 2022
- 2021
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
4D Molecular TherapeuticsChief Financial Officer
4D Molecular TherapeuticsChief Financial Officer
DepoMedFormer Senior Vice President and Chief Financial Officer
DepoMedChief Financial Officer and Senior Vice President
DepoMedChief Financial Officer and Senior Vice President
DepoMedChief Financial Officer and Senior Vice President
DepoMedChief Financial Officer and Senior Vice President
DepoMedChief Financial Officer and Senior Vice President
DepoMedChief Financial Officer and Senior Vice President
Source: SEC filings on April 12, 2023, April 8, 2019, March 27, 2018, July 14, 2017, April 14, 2016, and April 6, 2015.
Related executives
We found 23 more executives who work or worked at 4D Molecular Therapeutics and DepoMed.
David Kirn
4D Molecular Therapeutics
Chief Executive Officer
Fariborz Kamal
4D Molecular Therapeutics
Chief Operating Officer
Robert Kim
4D Molecular Therapeutics
Chief Medical Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics
Chief Medical Officer
Arthur Higgins
DepoMed
Chief Executive Officer
Stanley Bukofzer
DepoMed